Patients with severe obesity and type 2 diabetes and without bariatric surgery are assessed to determine comparative incidence of macrovascular disease.

Which is more efficacious in improving glucose levels in individuals with type 2 diabetes -- morning, afternoon, or evening exercise? Or does it matter? Follow the link to see.

Do you tell your patients with type 2 the best time to exercise? Follow the link to see how you and your colleagues compare.

In this week's Homerun Slides, we begin taking a look at Adam Brown's presentation as he answers the question, "Can diabetes apps make our lives easier?"

Autoimmunity persists in many patients even many years after diagnosis: Studies in patients with long disease duration suggest that beta-cell function may persist long after diagnosis in a significant proportion of patients. There is also evidence suggesting the co-existence of some low level of regeneration with chronic autoimmunity, as islet autoimmunity may also persist or perhaps be reactivated years after diagnosis. Indeed, significant proportions (30–40%) of islet or pancreas transplant recipients express one or more autoantibodies when evaluated prior to transplantation. Moreover, persisting autoreactive T-cell responses detected prior to transplantation correlate with islet graft failure on follow-up.

Study assesses glycemic variability via continuous glucose monitoring and compares it against incidence of diabetic retinopathy to determine if correlation exists.

Development of diabetic retinopathy found to be significantly reduced.

Automatic information processing studied to help find diabetic retinopathy on a larger scale.

Increased awareness of nontraditional risk factors may decrease disease diagnosis.

Trial examines differences in glycemic control and quality of life when using different insulin delivery methods.